Immediate Impact

56 standout
Sub-graph 1 of 22

Citing Papers

Pluripotent stem-cell-derived therapies in clinical trial: A 2025 update
2025 Standout
Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics
2025 Standout
1 intermediate paper

Works of Aderajew Waka being referenced

Proteasome inhibition with bortezomib induces a therapeutically relevant depletion of plasma cells in SLE but does not target their precursors
2018
The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus
2015

Author Peers

Author Last Decade Papers Cites
Aderajew Waka 195 46 102 193 6 353
Hugo R. Scherbarth 240 20 87 169 4 349
Tatsuhiro Harada 200 23 92 254 7 394
Maria J H Boumans 163 48 53 124 10 328
M. Safy 229 48 61 144 10 357
F H Gmelig Meyling 211 31 221 228 7 398
Aysche Landmann 281 25 85 162 9 347
Kumiko Yanase 89 20 102 162 7 374
Kurt Oelke 206 41 55 214 7 371
Maya Damianovich 142 16 56 92 10 324
Konstantia-Maria Chavele 121 32 41 261 7 393

All Works

Loading papers...

Rankless by CCL
2026